Skip to content
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Contact Us

Author: seraspec

Seraph Scientist publishes research on novel diagnostic methods

seraspec March 3, 2021

Micaela Trexler, a senior scientist at Seraph Biosciences, Inc., recently published a research article in the peer-reviewed journal, Plos One, based on her PhD dissertation […]

Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19

seraspec January 16, 2021
Source: Seraph Biosciences, Inc.

Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19 During the World War II era, MIT’s “Rad Lab” gave birth to […]

Seraph Vice President Gives Featured Interview with George Mason University

seraspec October 13, 2020
Source: George Mason University

Seraph Vice President Gives Featured Interview with George Mason University This month Shane Trexler, Seraph’s Vice President of Engineering and an alumnus of George Mason […]

Seraph Welcomes Naga Puttagunta!

seraspec October 5, 2020
Source: Seraph Biosciences, Inc.

Naga Puttagunta Joins Seraph Biosciences Naga Puttagunta, a seasoned software development executive, joined Seraph’s management team as Director of Cloud and Software Engineering this past […]

Seraph Welcomes Micaela Trexler!

seraspec September 29, 2020
Source: Seraph Biosciences, Inc.

Micaela Trexler Joins Seraph Biosciences This past week Micaela Trexler, a doctoral candidate of Biomedical Engineering at Wayne State University, joined Seraph’s product development team […]



Chairman Introduces Wayne Health

seraspec September 22, 2020
Source: Michigan State Medical Society

Seraph Chairman Introduces New Detroit Health Center This month marks the grand opening of the new 400 Mack Detroit Health Center in Midtown Detroit. Seraph […]




Seraph Awarded Diagnostic Development Initiative Grant

seraspec September 14, 2020
Source: Seraph Biosciences, Inc.

Seraph Awarded Diagnostic Development Initiative Grant (DETROIT) – Seraph Biosciences, Inc. (“Seraph”), creator of Seraspec®, was recently awarded promotional credits from Amazon Web Services (“AWS”) […]

Navigating a Pandemic

seraspec August 19, 2020
Source: Cronicle Press Tech News

Lessons Learned During COVID-19 Seraph’s management team continues to move forward with the development and commercialization of Seraspec® in spite of the COVID-19 pandemic. Joseph […]

COVID-19 Antibiotic Surge

seraspec June 15, 2020
Source: Seraph Biosciences, Inc.

Antibiotic use spikes amid COVID-19 hospitalizations Antibiotic-resistant superbugs threaten the very existence of our planet. We’re in a perpetual war, a war without and a […]

Combatting COVID-19

seraspec June 3, 2020
Source: Seraph Biosciences, Inc.

Seraph Chairman helps lead Detroit testing efforts for COVID-19 (DETROIT) –The devastating impact of the COVID-19 pandemic is far reaching, claiming countless lives and putting […]

Seraph Names Fouad Sayegh as Product VP

seraspec February 21, 2020
Source: Seraph Biosciences, Inc.

Seraph Names Fouad Sayegh as Product VP DETROIT, February 21, 2020 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to welcome Mr. Fouad Sayegh […]

Health Care Innovation

seraspec November 17, 2019
Source: Crain's Detroit Business

Health Care Innovation: Crain’s Detroit Recent innovative developments in Michigan include a statewide telestroke program at the University of Michigan, a precision medicine program at […]

Overuse of Antibiotics

seraspec November 15, 2019
Source: Detroit Free Press

Overuse of Antibiotics: Here’s How to Protect Yourself Nearly 3 million Americans get sick from drug-resistant infections, and 35,000 die every year, according to a new […]

Wired: Saving Antibiotics

seraspec November 8, 2019
Source: Wired

How Humans Might Save Antibiotics Last month, a massive group of business leaders and health officials gathered for one of the biggest events in the […]

Seraspec® acquiring

HealthQuake Summit

seraspec October 8, 2019
Source: Crain's Detroit Business

Dr. Shanley Addresses HealthQuake Summit   “We need to deal with anti-microbial resistant bacteria or all medical advances could be jeopardized. The vast majority of […]

BioIntelligence Revolution

seraspec July 2, 2019
Source: TEDxWayneStateU

TEDx Unveils “The BioIntelligence Revolution” The TEDx program has officially released Seraph Chairman, Dr. Charles Shanley’s second TEDx talk on the “BioIntelligence Revolution”. The talk […]

No Time to Wait

seraspec June 15, 2019
Source: World Health Organization

World Health Organization This past April, the World Health Organization’s Interagency Coordination Group on Antimicrobial Resistance (the “IAGC”) released a report to the Secretary-General of […]

Seraph Closes $4.2 Million Series B

seraspec April 28, 2019
Source: Seraph Biosciences, Inc.

Seraph Closes $4.2 Million Series B Round DETROIT, April 28, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that it has […]

TEDxWayneStateU

seraspec April 10, 2019
Source: TEDxWayneStateU

Seraph Chairman’s Second TEDx Talk Seraph Chairman, Dr. Charles Shanley, just gave his second TEDx talk this past Wednesday on the BioIntelligence Revolution. Dr. Shanley […]

Dr. Loveman Joins Seraph’s Board

seraspec February 19, 2019
Source: Seraph Biosciences, Inc.

Dr. Gary Loveman Joins Seraph’s Board DETROIT, Feb. 19, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that Dr. Gary Loveman, […]

  • 1
  • 2
  • Next Page »

Media inquiries

Lisa Vallee-Smith, Airfoil Group
vallee-smith@airfoilgroup.com
313-363-9981

Recent Posts

  • Seraph Scientist publishes research on novel diagnostic methods
  • Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19
  • Seraph Vice President Gives Featured Interview with George Mason University
  • Seraph Welcomes Naga Puttagunta!
  • Seraph Welcomes Micaela Trexler!


  • Chairman Introduces Wayne Health



  • Seraph Awarded Diagnostic Development Initiative Grant
  • Seraspec®
  • About Us
  • Management Team
  • Directors & Advisors
  • In the News
  • Careers
  • Terms and Conditions
  • Media Inquiries
  • Contact Us
1001 Woodward Ave. Suite 500 | Detroit, MI 48226 | 313.759.8009 | Seraph Biosciences, Inc.
Top